Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/04/21
End: 12/21/22
Due: 12/21/23
Phase: N/A
Priority: Normal
Start: 11/12/21
End: 02/21/22
Due: 02/21/23
Phase: N/A
Priority: Normal
Start: 07/23/21
End: 01/31/23
Due: 01/31/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms | NCT05000346 | Aquilon Pharmaceuticals S.A. | user2@example.com | None | 2021-11-04 | 2022-12-21 | 2023-12-21 | - | - | 2025-07-14 |
| Single-dose AQ001S PK Study in Healthy Volunteers | NCT05148312 | Aquilon Pharmaceuticals S.A. | user2@example.com | None | 2021-11-12 | 2022-02-21 | 2023-02-21 | - | - | 2025-07-14 |
| Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics | NCT04933383 | Aquilon Pharmaceuticals S.A. | user2@example.com | None | 2021-07-23 | 2023-01-31 | 2024-01-31 | - | - | 2025-07-14 |